. Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid. Alzheimers Dement. 2024 May;20(5):3179-3192. Epub 2024 Mar 16 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.